Bayer Aktiengesellschaft (BAYRY)
| Market Cap | 47.31B |
| Revenue (ttm) | 53.81B |
| Net Income (ttm) | -232.31M |
| Shares Out | n/a |
| EPS (ttm) | -0.24 |
| PE Ratio | n/a |
| Forward PE | 9.16 |
| Dividend | 0.02 (0.18%) |
| Ex-Dividend Date | Apr 29, 2025 |
| Volume | 1,934,184 |
| Average Volume | 545,114 |
| Open | 12.03 |
| Previous Close | 12.17 |
| Day's Range | 11.95 - 13.00 |
| 52-Week Range | 5.29 - 13.00 |
| Beta | 0.89 |
| RSI | 83.48 |
| Earnings Date | Feb 25, 2026 |
About Bayer Aktiengesellschaft
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin... [Read more]
Financial Performance
In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.
Financial numbers in EUR Financial StatementsNews
Bayer : U.S. Supreme Court To Review Durnell Case In Roundup Litigation
(RTTNews) - Bayer announced that the U.S. Supreme Court has agreed to review the Durnell case in the ongoing Roundup litigation. The Court's decision follows a petition filed by Monsanto in April 2025...
Supreme Court to hear Bayer's appeal to block thousands of Roundup weedkiller lawsuits
Bayer is arguing that consumers should not be able to sue it under state law for failing to warn that Roundup increases cancer risk because the Environmental Protection Agency has found no such risk a...
Bayer (BAYZF) Sees 5% Gain as U.S. Supreme Court Agrees to Hear Roundup Appeal
Bayer (BAYZF) Sees 5% Gain as U.S. Supreme Court Agrees to Hear Roundup Appeal
Bayer welcomes the U.S. Supreme Court decision to review the Durnell case in the Roundup™ litigation
LEVERKUSEN--(BUSINESS WIRE)--The U.S. Supreme Court today announced that it will review the Durnell Roundup™ case. Monsanto petitioned the court to hear Durnell in April 2025 and address the split in ...
Supreme Court takes up Bayer’s bid to limit Roundup weedkiller liability
The Supreme Court on Friday took up a bid from Bayer to limit liability for pesticide makers, including Bayer’s Roundup weedkiller, which has become the subject of numerous cancer suits. The court sai...
Bayer gains after U.S. Supreme Court grants hearing on Roundup suits
Bayer (BAYZF) shares jump after Supreme Court agrees to hear Roundup appeal, impacting 67,000 lawsuits.
Supreme Court to Hear Bayer's Challenge to Roundup Weedkiller Cases
High court gives company hope in its effort to mitigate long-running litigation that has cost it billions of dollars.
US Supreme Court to hear Bayer's bid to curb Roundup cases
The U.S. Supreme Court agreed on Friday to hear Bayer's bid to sharply limit lawsuits claiming that the company's Roundup weedkiller causes cancer and potentially avert billions of dollars in damages.
Winter woes? Fatigue and body aches lead common complaints
Body aches (28%), fatigue (26%), feeling “off” (23%) and a runny nose (21%) are the four horsemen of a subpar day, according to new research. A survey of 2,000 adults conducted by Talker Research for ...
Bayer Shares Surge as Partner Forecasts Sales Growth for Prostate-Cancer Drug
DAX Slips After Hitting New Record High; Bayer, RWE Post Strong Gains
(RTTNews) - German stocks climbed higher Wednesday morning with investors reacting to some encouraging corporate updates, and robust trade data from China that showed the resilience of the manufacturi...
Bayer AG at JPMorgan Healthcare Conference Transcript
Bayer AG at JPMorgan Healthcare Conference Transcript
Bayer targets return to mid-single-digit pharma growth by 2027
The pharmaceuticals and agriculture group Bayer aims to return its pharmaceuticals business to mid-single-digit percentage growth by no later than 2027 and lift operating margins to about 30% by 2030,...
Bayer Aktiengesellschaft (BAYRY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Bayer Accelerates Pharma Growth on High-Value Portfolio
SAN FRANCISCO--(BUSINESS WIRE)--On the occasion of the 44th J.P. Morgan Healthcare Conference in San Francisco, Bayer AG today unveiled the strategic focus for its Pharmaceuticals Division in 2026. Ca...
LARGE CAP INTERNATIONAL PORTFOLIO Buys Shares of Bayer AG (XTER:BAYN)
LARGE CAP INTERNATIONAL PORTFOLIO Buys Shares of Bayer AG (XTER:BAYN)
Actress and Menopause Advocate Gabrielle Union-Wade Partners with Bayer in the Lynkuet® (elinzanetant) ‘Life Doesn't Stop for a Hot Flash' Campaign for Moderate to Severe Hot Flashes Due to Menopause
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced it has partnered with actress and menopause advocate Gabrielle Union-Wade on the ‘Life Doesn't Stop for a Hot Flash' campaign, which speaks to wo...
Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus
BERLIN & NAPLES, Fla.--(BUSINESS WIRE)--Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developi...
Bayer Accelerates Growth With siRNA, AI Deals and Pipeline Progress
Bayer AG enters into collaborations to develop a heart-targeted siRNA therapy and AI technology, expanding its push into next-gen genetic medicines.
Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy
BERLIN & BOSTON--(BUSINESS WIRE)--Bayer and Soufflé Therapeutics™, an innovative biotech company that discovers and develops cell-selective genetic therapies, today announced a strategic collaboration...
Bayer and Cradle enter collaboration to enhance AI-enabled antibody discovery and optimization
Cradle provides a scientific AI software platform focused on protein engineering Bayer continues to utilize AI in R&D, reinforcing commitment to modernize and scale its drug discovery and development ...
Bayer sues COVID vaccine makers over mRNA technology
Bayer's Monsanto sued COVID-19 vaccine makers Pfizer , BioNTech and Moderna in Delaware federal court on Tuesday for allegedly misusing its messenger RNA technology in manufacturing their vaccines, a ...
Pesticide industry ‘immunity shield’ stripped from US appropriations bill
Democrats and the Make America Healthy Again movement pushed back on the rider in a funding bill led by Bayer In a setback for the pesticide industry, Democrats have succeeded in removing a rider from...
Bayer to Present Updates on Pharma Growth Strategy and Pipeline Advancements at J.P. Morgan's 44th Annual Healthcare Conference
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer will participate in the 44th J.P. Morgan Healthcare Conference 2026 taking place from January 12–15, 2026 in San Francisco. Stefan Oelrich, Member of the Board o...
BAYRY's 2025 Revival: Will the Momentum Continue in 2026?
BAYRY shares have risen 121.6% in a year as new FDA approvals, pipeline wins and litigation updates fuel a sharp turnaround.